Analysts expect Aphria Inc. (NYSE:APHA) to report $-0.02 EPS on October, 11.They anticipate $0.09 EPS change or 128.57 % from last quarter’s $0.07 EPS. The stock increased 2.79% or $0.19 during the last trading session, reaching $6.99. About 2.56 million shares traded. Aphria Inc. (NYSE:APHA) has declined 37.03% since September 11, 2018 and is downtrending. It has underperformed by 37.03% the S&P500.
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company has market cap of $1.57 billion. The firm offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It has a 23.38 P/E ratio. It serves patients and health professionals.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.